GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 48 filers reported holding GALERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $6,552,000 | +4.1% | 2,100,000 | -14.6% | 0.51% | +21.9% |
Q1 2023 | $6,295,094 | +71.8% | 2,459,021 | 0.0% | 0.42% | +81.2% |
Q4 2022 | $3,663,941 | -14.4% | 2,459,021 | 0.0% | 0.23% | +12.3% |
Q3 2022 | $4,279,000 | +33.8% | 2,459,021 | 0.0% | 0.20% | +29.9% |
Q2 2022 | $3,197,000 | -45.4% | 2,459,021 | 0.0% | 0.16% | -49.2% |
Q1 2022 | $5,852,000 | -48.2% | 2,459,021 | 0.0% | 0.31% | -42.1% |
Q4 2021 | $11,287,000 | -43.3% | 2,459,021 | 0.0% | 0.53% | -48.2% |
Q3 2021 | $19,918,000 | -17.6% | 2,459,021 | 0.0% | 1.03% | -3.9% |
Q2 2021 | $24,172,000 | +11.4% | 2,459,021 | 0.0% | 1.07% | +19.6% |
Q1 2021 | $21,689,000 | -28.4% | 2,459,021 | -16.9% | 0.90% | -31.0% |
Q4 2020 | $30,271,000 | -1.8% | 2,959,021 | -13.2% | 1.30% | -15.2% |
Q3 2020 | $30,818,000 | +26.6% | 3,409,021 | 0.0% | 1.53% | -2.6% |
Q2 2020 | $24,340,000 | -24.8% | 3,409,021 | 0.0% | 1.57% | -27.3% |
Q1 2020 | $32,386,000 | -27.8% | 3,409,021 | 0.0% | 2.16% | -25.2% |
Q4 2019 | $44,863,000 | – | 3,409,021 | – | 2.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 2,036,495 | $16,496,000 | 3.47% |
Worth Venture Partners, LLC | 472,180 | $3,825,000 | 1.72% |
Nan Fung Group Holdings Ltd | 613,223 | $4,967,000 | 1.59% |
Sofinnova Investments, Inc. | 3,083,712 | $24,978,000 | 1.48% |
Novo Holdings A/S | 2,459,021 | $19,918,000 | 1.03% |
Altium Capital Management LP | 300,605 | $2,435,000 | 0.64% |
NEA Management Company, LLC | 4,362,986 | $35,340,000 | 0.42% |
Tekla Capital Management LLC | 898,374 | $7,277,000 | 0.23% |
Taylor Wealth Management Partners | 58,012 | $470,000 | 0.17% |
FRAZIER MANAGEMENT LLC | 241,000 | $1,952,000 | 0.16% |